Global Blood Therapeutics, Inc. short interest in 2021
In 2021, Global Blood Therapeutics, Inc.'s disclosed short interest ran from 18.22% of shares outstanding on 15 Jan 2021 to 13.34% on 31 Dec 2021, a change of -4.88 percentage points. The year's high was 20.05% on 30 Jun 2021 and its low 8.98% on 15 Nov 2021, averaging 16.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.94 days on 28 May 2021. Full history: Global Blood Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 18.22% (15 Jan 2021)
- End of year
- 13.34% (31 Dec 2021)
- Change
- -4.88 pp
- High
- 20.05% (30 Jun 2021)
- Low
- 8.98% (15 Nov 2021)
- Average
- 16.22%
- Highest days to cover
- 19.94 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 18.22% | 11.69 | |
| 29 Jan 2021 | 18.38% | 9.73 | |
| 12 Feb 2021 | 18.67% | 18.85 | |
| 26 Feb 2021 | 19.19% | 9.73 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 19.06% | 13.84 | |
| 31 Mar 2021 | 18.57% | 16.51 | |
| 15 Apr 2021 | 19.26% | 15.29 | |
| 30 Apr 2021 | 18.63% | 19.06 | |
| 14 May 2021 | 19.38% | 12.11 | 10-Q filed, results (8-K) |
| 28 May 2021 | 18.47% | 19.94 | |
| 15 Jun 2021 | 18.62% | 12.98 | |
| 30 Jun 2021 | 20.05% | 6.22 | |
| 15 Jul 2021 | 19.55% | 12.62 | |
| 30 Jul 2021 | 18.92% | 9.47 | |
| 13 Aug 2021 | 18.87% | 8.15 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 17.00% | 9.09 | |
| 15 Sep 2021 | 14.92% | 9.16 | |
| 30 Sep 2021 | 10.60% | 4.81 | |
| 15 Oct 2021 | 9.93% | 5.70 | |
| 29 Oct 2021 | 10.27% | 5.68 | |
| 15 Nov 2021 | 8.98% | 3.81 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.30% | 6.60 | |
| 15 Dec 2021 | 11.10% | 2.50 | |
| 31 Dec 2021 | 13.34% | 5.59 |
See also: Global Blood Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.